Skip to main content
. 2013 Jul 11;109(3):641–650. doi: 10.1038/bjc.2013.369

Figure 4.

Figure 4

Kaplan–Meier analysis in the validation set (n=70) showing estimated biochemical recurrence (BCR)-free probability in patients with high (above median) or low (below median) levels of circulating miRNAs. Curves were compared using a log-rank test. P-values and hazard ratios (HRs; 95% confidence interval in parentheses) are shown.